Tuvirumab, CAS 138660-97-6

Product Description: Tuvirumab (OST 577; SDZ-OST 577) is a human IgG1 subclass monoclonal antibody directed against HBV surface antigen (HBsAg). Tuvirumab binds specifically and with high affinity (K=3.6 nM) to HBsAg. Tuvirumab has the potential for chronic hepatitis B research[1][2].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]N Ogata, et al. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):3014-8./[2]R A Heijtink, et al. Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexes. J Med Virol. 2001 Aug;64(4):427-34.

CAS Number: 138660-97-6

Molecular Weight: N/A

Research Area: Infection

Solubility: H2O

Target: HBV

• Artikelnummer: MEXHY-P99541-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99541-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated